Table 2.
Minimal common regions (MCRs) of overlapping GISTIC-defined peaks and mapped genes/refseqs and miRs.
| Region CNA | Overlapping Peak-MCRs | |||
|---|---|---|---|---|
| Start (Mbp) | End (Mbp) | n | Candidate Genes/MiRs | |
| A2p16.3-p14 | 60,993,696 | 61,147,244 | 2 | REL, PAPOLG |
| A3q22.1-q29 | 195,262,873 | 196,054,003 | 15 | TRFC (CD71), PCYTIA, MUC20, MUC4, MIR570 |
| A6p22.1-p12.3 | 32,690,831 | 32,709,466 | 1 | HLA-DQA2 |
| Achr7 | 1,017,099 | 1,081,180 | 3 | CYP2W1, C7orf50, MIR339 |
| 101,059,950 | 101,481,721 | 3 | COL26A1, MYL10, CUX1 | |
| A9q34.11-q34.3 | 138,543,735 | 140,343,466 | 81 | CAD9, NOTCH1, EGLF7, MIR4673, MIR4674 |
| A12p11.21-q21.33 | 70,345,927 | 70,719,344 | 1 | CNOT2 |
| A13q31.3-q32.1 | 92,020,763 | 92,032,734 | 0 | |
| A21q22.13-q22.3 | 43,959,706 | 44,358,680 | 5 | SLC37A1, PDE9A, WDR4, NDUVF3, HERV-Fb1 |
| D1p36.33-p36.22 | 2,926,556 | 3,762,888 | 12 | TP73, PRDM16, MIR551A |
| D1p13.2-p12 | 117,070,416 | 117,111,959 | 1 | CD58 |
| D6p22.1-p21.32 | 31,167,499 | 31,326,959 | 3 | HCG27, HLA-B, HLA-C |
| D6p12.3-q27 | 138,049,196 | 138,241,766 | 1 | TNFAIP3 |
| D8p23.3-p11.23 | 19,362,769 | 19,667,874 | 1 | CSGALNACT1 |
| D9p24.3-p21.1 | 5,106,681 | 5,109,576 | 1 | JAK2 |
| 21,978,347 | 21,984,369 | 2 | CDKN2A, MTAP | |
| D10q23.2-23.32 | 90,597,629 | 90,775,628 | 5 | FAS, FAS-AS1, ANKRD22, STAMBPL1, ACTA2 |
| D15q12-q24.1 | 43,133,828 | 43,370,177 | 2 | TTBK2, UBR1 |
| 44,939,261 | 45,026,122 | 4 | SPG11, PATL2, B2M, TRIM69 | |
| D17p13.3-q11.1 | 7,841,724 | 7,920,934 | 2 | CNTROB, GUCY2D |
| D19p13.3-p13.2 | 6,535,980 | 6,620,909 | 1 | CD70 |